NanoEcho AB (publ) (STO:NANECH)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0458
-0.0060 (-11.58%)
At close: Apr 28, 2026
-60.10%
Market Cap 20.96M
Revenue (ttm) 487.00K
Net Income (ttm) -15.65M
Shares Out 457.54M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,967,133
Average Volume 3,454,918
Open 0.0512
Previous Close 0.0518
Day's Range 0.0350 - 0.0528
52-Week Range 0.0200 - 0.1800
Beta n/a
RSI 72.69
Earnings Date Apr 30, 2026

About NanoEcho AB

NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol NANECH
Full Company Profile

Financial Performance

In 2025, NanoEcho AB's revenue was 487,000, a decrease of -93.30% compared to the previous year's 7.27 million. Losses were -15.65 million, 3.35% more than in 2024.

Financial Statements

News

NanoEcho AB Earnings Call Transcript: Q2 2024

Transitioned to clinical phase after completing product development and regulatory milestones. Net loss increased to SEK 8.7 million with no revenue, but a successful rights issue secured 12 months of capital for clinical trials. Market approval is targeted for H2 2027.

1 year ago - Transcripts